|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.74 USD | -1.14% |
|
+1.84% | +26.81% |
| 07-15 | Bruker Acquires Noscendo's Disqver Clinical Metagenomics Platform | MT |
| 07-14 | Bruker Corporation acquired DISQVER Clinical Metagenomics Platform of Noscendo GmbH. | CI |
| Market Cap | 9.09B 7.97B 7.4B 6.8B 12.81B 878B 13B 88.12B 34.49B 429B 34.14B 33.4B 1,483B | P/E 2026 * |
59x | P/E 2027 * | 44.8x |
|---|---|---|---|---|---|
| Enterprise Value | 10.57B 9.27B 8.6B 7.9B 14.89B 1,020B 15.11B 102B 40.1B 499B 39.69B 38.84B 1,725B | EV / Sales 2026 * |
2.95x | EV / Sales 2027 * | 2.77x |
| Free-Float |
60.72% | Yield 2026 * |
0.34% | Yield 2027 * | 0.34% |
Last Transcript: Bruker Corporation
| 1 day | -1.14% | ||
| 1 week | +1.84% | ||
| Current month | -0.73% | ||
| 1 month | +5.68% | ||
| 3 months | +50.59% | ||
| 6 months | +14.64% | ||
| Current year | +26.81% |
| 1 week | 54.8 |  | 60.97 |
| 1 month | 54.8 | | 63.04 |
| Current year | 32.36 | | 64.54 |
| 1 year | 28.53 | | 64.54 |
| 3 years | 28.53 | | 94.86 |
| 5 years | 28.53 | | 94.86 |
| 10 years | 19.58 | | 94.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Laukien
CEO | Chief Executive Officer | 66 | 1991-01-31 |
Gerald Herman
DFI | Director of Finance/CFO | 68 | 2018-03-16 |
Thorsten Thiel
SAM | Sales & Marketing | - | 2010-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Linton
BRD | Director/Board Member | 79 | 2000-01-31 |
Frank Laukien
CHM | Chairman | 66 | 1991-01-31 |
Richard Packer
BRD | Director/Board Member | 68 | 2007-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 | Fiscal year | Executive/Senior Manager | 6,000 | 0.0039% | ||
| 7/1/26 | Other | President BMID Group | 10,154 | 0.0067% | ||
| 6/15/26 | Fiscal year | Executive/Senior Manager | 6,000 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.14% | +1.84% | +53.97% | -20.74% | 9.09B | |
| +0.57% | -1.65% | +23.11% | -6.36% | 196B | |
| +0.07% | -10.78% | -5.67% | -29.99% | 126B | |
| -2.68% | -12.41% | -33.33% | +1.20% | 120B | |
| -0.51% | -0.16% | -58.35% | -19.17% | 63.87B | |
| -0.21% | -3.32% | +10.58% | -8.86% | 48.58B | |
| +0.17% | -0.52% | -24.32% | -32.66% | 43.93B | |
| +0.45% | -0.93% | +14.86% | +4.58% | 37.69B | |
| +0.89% | -1.09% | +29.00% | +28.44% | 36.41B | |
| -0.86% | +1.99% | +87.07% | +0.20% | 28.88B | |
| Average | -0.07% | -2.86% | +9.69% | -8.34% | 71.04B | |
| Weighted average by Cap. | +0.16% | -4.90% | +0.19% | -9.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.59B 3.14B 2.92B 2.68B 5.06B 346B 5.13B 34.78B 13.61B 169B 13.47B 13.18B 585B | 3.74B 3.28B 3.04B 2.8B 5.27B 361B 5.35B 36.26B 14.19B 177B 14.05B 13.74B 610B |
| Net income | 155M 136M 126M 116M 218M 14.95B 221M 1.5B 588M 7.32B 582M 569M 25.27B | 203M 178M 165M 152M 286M 19.6B 290M 1.97B 771M 9.59B 763M 746M 33.14B |
| Net Debt | 1.48B 1.3B 1.2B 1.11B 2.08B 143B 2.12B 14.34B 5.61B 69.89B 5.56B 5.44B 241B | 1.27B 1.11B 1.03B 949M 1.79B 122B 1.81B 12.3B 4.81B 59.93B 4.76B 4.66B 207B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | US$59.74 | -1.14% | 1,350,550 |
| 26-07-21 | US$60.43 | +7.58% | 2,775,002 |
| 26-07-20 | US$56.17 | -3.54% | 1,838,859 |
| 26-07-17 | US$58.23 | -1.72% | 2,325,641 |
| 26-07-16 | US$59.25 | +1.01% | 1,556,775 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BRKR Stock
Select your edition
All financial news and data tailored to specific country editions
